IBDEI16K ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20844,1,4,0)
 ;;=4^Fibrocystic Breast
 ;;^UTILITY(U,$J,358.3,20844,2)
 ;;=^46167
 ;;^UTILITY(U,$J,358.3,20845,0)
 ;;=V10.3^^112^1293^28
 ;;^UTILITY(U,$J,358.3,20845,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20845,1,3,0)
 ;;=3^V10.3
 ;;^UTILITY(U,$J,358.3,20845,1,4,0)
 ;;=4^Hx Of Breast Cancer
 ;;^UTILITY(U,$J,358.3,20845,2)
 ;;=^295217
 ;;^UTILITY(U,$J,358.3,20846,0)
 ;;=V10.43^^112^1293^29
 ;;^UTILITY(U,$J,358.3,20846,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20846,1,3,0)
 ;;=3^V10.43
 ;;^UTILITY(U,$J,358.3,20846,1,4,0)
 ;;=4^Hx Of Ovarian Cancer
 ;;^UTILITY(U,$J,358.3,20846,2)
 ;;=^295221
 ;;^UTILITY(U,$J,358.3,20847,0)
 ;;=611.72^^112^1293^31
 ;;^UTILITY(U,$J,358.3,20847,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20847,1,3,0)
 ;;=3^611.72
 ;;^UTILITY(U,$J,358.3,20847,1,4,0)
 ;;=4^Lump Or Mass In Breast
 ;;^UTILITY(U,$J,358.3,20847,2)
 ;;=^72018
 ;;^UTILITY(U,$J,358.3,20848,0)
 ;;=625.9^^112^1293^36
 ;;^UTILITY(U,$J,358.3,20848,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20848,1,3,0)
 ;;=3^625.9
 ;;^UTILITY(U,$J,358.3,20848,1,4,0)
 ;;=4^Pelvic Pain
 ;;^UTILITY(U,$J,358.3,20848,2)
 ;;=^123993
 ;;^UTILITY(U,$J,358.3,20849,0)
 ;;=627.1^^112^1293^37
 ;;^UTILITY(U,$J,358.3,20849,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20849,1,3,0)
 ;;=3^627.1
 ;;^UTILITY(U,$J,358.3,20849,1,4,0)
 ;;=4^Postmenopausal Bleeding
 ;;^UTILITY(U,$J,358.3,20849,2)
 ;;=^97040
 ;;^UTILITY(U,$J,358.3,20850,0)
 ;;=616.10^^112^1293^51
 ;;^UTILITY(U,$J,358.3,20850,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20850,1,3,0)
 ;;=3^616.10
 ;;^UTILITY(U,$J,358.3,20850,1,4,0)
 ;;=4^Vaginitis/Vaginal Infection
 ;;^UTILITY(U,$J,358.3,20850,2)
 ;;=^125233
 ;;^UTILITY(U,$J,358.3,20851,0)
 ;;=626.0^^112^1293^8
 ;;^UTILITY(U,$J,358.3,20851,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20851,1,3,0)
 ;;=3^626.0
 ;;^UTILITY(U,$J,358.3,20851,1,4,0)
 ;;=4^Amenorrhea
 ;;^UTILITY(U,$J,358.3,20851,2)
 ;;=^5871
 ;;^UTILITY(U,$J,358.3,20852,0)
 ;;=783.0^^112^1293^9
 ;;^UTILITY(U,$J,358.3,20852,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20852,1,3,0)
 ;;=3^783.0
 ;;^UTILITY(U,$J,358.3,20852,1,4,0)
 ;;=4^Anorexia
 ;;^UTILITY(U,$J,358.3,20852,2)
 ;;=^7939
 ;;^UTILITY(U,$J,358.3,20853,0)
 ;;=V76.10^^112^1293^11
 ;;^UTILITY(U,$J,358.3,20853,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20853,1,3,0)
 ;;=3^V76.10
 ;;^UTILITY(U,$J,358.3,20853,1,4,0)
 ;;=4^Breast Cancer Screening
 ;;^UTILITY(U,$J,358.3,20853,2)
 ;;=^317968
 ;;^UTILITY(U,$J,358.3,20854,0)
 ;;=616.0^^112^1293^14
 ;;^UTILITY(U,$J,358.3,20854,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20854,1,3,0)
 ;;=3^616.0
 ;;^UTILITY(U,$J,358.3,20854,1,4,0)
 ;;=4^Cervicitis
 ;;^UTILITY(U,$J,358.3,20854,2)
 ;;=^21925
 ;;^UTILITY(U,$J,358.3,20855,0)
 ;;=078.10^^112^1293^26
 ;;^UTILITY(U,$J,358.3,20855,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20855,1,3,0)
 ;;=3^078.10
 ;;^UTILITY(U,$J,358.3,20855,1,4,0)
 ;;=4^Genital Warts
 ;;^UTILITY(U,$J,358.3,20855,2)
 ;;=^295787
 ;;^UTILITY(U,$J,358.3,20856,0)
 ;;=625.3^^112^1293^18
 ;;^UTILITY(U,$J,358.3,20856,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20856,1,3,0)
 ;;=3^625.3
 ;;^UTILITY(U,$J,358.3,20856,1,4,0)
 ;;=4^Dysmenorrhea
 ;;^UTILITY(U,$J,358.3,20856,2)
 ;;=^37592
 ;;^UTILITY(U,$J,358.3,20857,0)
 ;;=625.0^^112^1293^19
 ;;^UTILITY(U,$J,358.3,20857,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20857,1,3,0)
 ;;=3^625.0
 ;;^UTILITY(U,$J,358.3,20857,1,4,0)
 ;;=4^Dyspareunia
 ;;^UTILITY(U,$J,358.3,20857,2)
 ;;=^37604
 ;;^UTILITY(U,$J,358.3,20858,0)
 ;;=788.1^^112^1293^23
 ;;^UTILITY(U,$J,358.3,20858,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20858,1,3,0)
 ;;=3^788.1
 ;;
 ;;$END ROU IBDEI16K
